Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Depreciation and Depletion: 2016-2024

Historic Depreciation and Depletion for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $13.6 million.

  • Organogenesis Holdings' Depreciation and Depletion rose 12.86% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year increase of 14.10%. This contributed to the annual value of $13.6 million for FY2024, which is 30.39% up from last year.
  • Organogenesis Holdings' Depreciation and Depletion amounted to $13.6 million in FY2024, which was up 30.39% from $10.4 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Depreciation and Depletion registered a high of $13.6 million during FY2024, and its lowest value of $4.4 million during FY2020.
  • Its 3-year average for Depreciation and Depletion is $10.0 million, with a median of $10.4 million in 2023.
  • Data for Organogenesis Holdings' Depreciation and Depletion shows a peak YoY surged of 78.75% (in 2023) over the last 5 years.
  • Over the past 5 years, Organogenesis Holdings' Depreciation and Depletion (Yearly) stood at $4.4 million in 2020, then skyrocketed by 30.26% to $5.8 million in 2021, then increased by 1.11% to $5.8 million in 2022, then soared by 78.75% to $10.4 million in 2023, then soared by 30.39% to $13.6 million in 2024.